Sun Pharma and HCL Tech find place in MFs' top ten picks

Fund managers allocate 2.5% of equity assets; oust Bharti Airtel and BPCL

Chandan Kishore Kant Mumbai
Last Updated : Jun 15 2015 | 11:36 PM IST
The top 10 stock picks of local equity fund managers has undergone a change, with Dilip Shanghvi-owned Sun Pharmaceutical Industries and IT major HCL Technologies making it to the list. Telecom giant Bharti Airtel and state-owned oil marketing company Bharat Petroleum Corporation (BPCL) are no longer on the list.

ALSO READ: Mutual funds' exposure to IT stocks hits 4-month low in April
 
It was only recently that these two companies were among fund managers’ top 10 preferred stocks. The replacement came during a month when key stock indices remained weak marked with steep volatility. Sun Pharmaceuticals, in particular, deserves special mention as in late April minority shareholder Daiichi Sankyo had offloaded its entire 8.93 per cent stake. The stock had fallen over eight per cent as there was an increased supply of nearly 214 million shares.  Fund managers had purchased about 27 million new shares of the company at a cost price of Rs 2,534 crore. With this, they more than doubled the number of shares in their holdings to 47.18 million shares against 20.18 million shares. As on 31 May, fund mangers allocated 1.25 per cent of total equity assets or Rs 3,727 crore.

ALSO READ: Mutual funds log Rs 1 lakh cr inflows in Apr-May
 
“The stock had dipped about 25 per cent in a short time and that was a good opportunity to pick up the cheap stocks. Though the counter has further corrected from that level, I believe it is still a compelling case to buy,” said equity head of a large fund house.

It is probably the first time after a long phase that a pharma company has emerged among the most sought after stocks by fund managers. HCL Technologies, on the other hand, is the second IT stock to be in the top most allocated company in fund managers' radar along with Infosys. Fund managers believe IT could be a good contrary bet as stocks have already been beaten a lot. Put together, fund managers have allocated Rs 3,714 crore as on May 31.

ALSO READ: HCL Tech Q3 results well below estimates

Research analyst with Angel Broking has maintained a buy on HCL Technologies with a target of Rs 683. In its report, the brokerage said, “The (HCL) management remains confident of reverting back to the original profitability by FY18. We expect a CAGR of 20 per cent in dollar revenue over 2015 to 2017.”

As on 31 May, the overall equity asset under management stood at Rs 3.65 lakh crore.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jun 15 2015 | 10:45 PM IST

Next Story